Q1 2026

- 23 April 2026 - 0 mins read

Q1 2026 Results Call

Date & Time: April 23, 2pm CET

Webcast Link
Analyst Q&A (by Phone Only)

About Ipsen

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries, and our partnerships around the world, enable us to bring medicines to patients in more than 100 countries.

If you are experiencing difficulties registering for the investor and analyst conference call, please contact: khalid.deojee@ipsen.com